Literature DB >> 19933595

Gout: an independent risk factor for all-cause and cardiovascular mortality.

Chang-Fu Kuo1, Lai-Chu See, Shue-Fen Luo, Yu-Shien Ko, Yu-Sheng Lin, Jawl-Shan Hwang, Chi-Ming Lin, Hung-Wei Chen, Kuang-Hui Yu.   

Abstract

OBJECTIVE: The relation of gout and hyperuricaemia to cardiovascular diseases has been well documented. This study investigates the survival impact of both gout and hyperuricaemia.
METHODS: The subjects of this study comprised participants of a health screening programme conducted by the Chang Gung Memorial Hospital in Taiwan from 2000 to 2006. The status and causes of death were ascertained by the Taiwan National Death Registry 2000-07. Cox proportional hazard model was performed to examine the association.
RESULTS: Among 61 527 subjects, 1383 deaths (198 cardiovascular deaths) were identified, corresponding to a crude mortality rate of 4.86 deaths per 1000 person-years. Crude mortality rates were 4.50, 5.61 and 10.46 deaths per 1000 person-years for subjects with normouricaemia, hyperuricaemia and gout, respectively. Compared with subjects with normouricaemia, the hazard ratios (HRs) of all-cause mortality were 1.46 (95% CI 1.12, 1.91) for individuals with gout and 1.07 (95% CI 0.94, 1.22) for those with hyperuricaemia, respectively, after adjustments were made for age, sex, component number of metabolic syndrome and proteinuria. The adjusted HRs of cardiovascular mortality were 1.97 (95% CI 1.08, 3.59) for individuals with gout and 1.08 (95% CI 0.78, 1.51) for those with hyperuricaemia. Moreover, the risk of all-cause or cardiovascular mortality for gout remained unchanged when limiting the data to those with an estimated glomerular filtration of >60 ml/min/1.73 m(2).
CONCLUSION: This study demonstrates a link of gout, not hyperuricaemia, with a higher risk of death from all causes and cardiovascular diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19933595     DOI: 10.1093/rheumatology/kep364

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  65 in total

1.  The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012.

Authors:  Sharan K Rai; J Antonio Aviña-Zubieta; Natalie McCormick; Mary A De Vera; Kam Shojania; Eric C Sayre; Hyon K Choi
Journal:  Semin Arthritis Rheum       Date:  2016-08-17       Impact factor: 5.532

2.  [Diagnosis and management of gout in Austria. Survey of current practice considering the EULAR recommendations].

Authors:  J Sautner
Journal:  Z Rheumatol       Date:  2014-11       Impact factor: 1.372

3.  Cause-Specific Mortality in Gout: Novel Findings of Elevated Risk of Non-Cardiovascular-Related Deaths.

Authors:  Ana Beatriz Vargas-Santos; Tuhina Neogi; Geraldo da Rocha Castelar-Pinheiro; Meliha C Kapetanovic; Aleksandra Turkiewicz
Journal:  Arthritis Rheumatol       Date:  2019-09-25       Impact factor: 10.995

4.  Factors associated with gout in South Koreans: analysis using the National Health Insurance Corporation and the National Health Screening Exam databases.

Authors:  Chan Hee Lee; Na Young Sung; Jisoo Lee; Sang-Cheol Bae
Journal:  Clin Rheumatol       Date:  2013-02-10       Impact factor: 2.980

5.  Presence of tophi is a predictive factor of arterial stiffness in patients with gout.

Authors:  WooSeong Jeong; Seung-Jae Joo; Jinsoek Kim; Jae-Geun Lee; Joon Hyouk Choi
Journal:  Rheumatol Int       Date:  2019-06-01       Impact factor: 2.631

Review 6.  [Full version of the S2e guidelines on gouty arthritis : Evidence-based guidelines of the German Society of Rheumatology (DGRh)].

Authors:  U Kiltz; R Alten; M Fleck; K Krüger; B Manger; U Müller-Ladner; H Nüßlein; M Reuss-Borst; A Schwarting; H Schulze-Koops; A Tausche; J Braun
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

7.  Systemic staging for urate crystal deposits with dual-energy CT and ultrasound in patients with suspected gout.

Authors:  Alexander Huppertz; Kay-Geert A Hermann; Torsten Diekhoff; Moritz Wagner; Bernd Hamm; Wolfgang A Schmidt
Journal:  Rheumatol Int       Date:  2014-03-12       Impact factor: 2.631

8.  A profile of gout patients in Sarawak.

Authors:  C L Teh; Y K Cheong; H N Ling; P L Chan; T Chan; G R Ling
Journal:  Rheumatol Int       Date:  2011-11-19       Impact factor: 2.631

9.  Coexistent Hyperuricemia and Gout in Rheumatoid Arthritis: Associations With Comorbidities, Disease Activity, and Mortality.

Authors:  Andrew Chiou; Bryant R England; Harlan Sayles; Geoffrey M Thiele; Michael J Duryee; Joshua F Baker; Namrata Singh; Grant W Cannon; Gail S Kerr; Andreas Reimold; Angelo Gaffo; Ted R Mikuls
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-06-07       Impact factor: 4.794

10.  [Austrian 3e-recommendations for diagnosis and management of gout 2013].

Authors:  Judith Sautner; Johann Gruber; Manfred Herold; Jochen Zwerina; Burkhard F Leeb
Journal:  Wien Klin Wochenschr       Date:  2013-12-03       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.